Lombard Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015; Reaffirms Revenue Guidance for the Year 2015
For the nine months, the company's revenue was $12,171,000 compared with $8,519,000 a year ago. Operating loss was $27,373,000 compared with $27,209,000 a year ago. Loss before taxation was $27,850,000 compared with $27,079,000 a year ago. Loss for the period was $26,199,000 compared with $26,469,000 a year ago. Basic and diluted loss per ordinary share from continuing operations was 153.8 cents compared with 189.0 cents a year ago. Net cash outflow from operating activities was $25,509,000 compared with $24,016,000 a year ago. Purchase of property, plant and equipment was $1,017,000 million compared with $1,519,000 a year ago. Purchase of intangible assets was $15,000 million compared with $245,000 million a year ago.
The company reaffirmed that it expects to achieve revenue for 2015 of between $15 million and $16 million.